Neil Palmisiano

5PUBLICATIONS
50CO-AUTHORS
Haematological tumoursMedical infection agents (incl. prions)Immunogenetics (incl. genetic immunology)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 17, 2024
A phase 1 trial of venetoclax in combination with liposomal vincristine in patients with relapsed or refractory B-cell or T-cell acute lymphoblastic leukemia: Results from the ECOG-ACRIN EA9152 protocol.

Neil D Palmisiano, Ju-Whei Lee, David F Claxton

|Feb 22, 2023
Survival of TP53-mutated acute myeloid leukemia patients receiving allogeneic stem cell transplantation after first induction or salvage therapy: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND).

Talha Badar, Ehab Atallah, Rory Shallis

|Aug 09, 2022
miR-196b-TLR7/8 Signaling Axis Regulates Innate Immune Signaling and Myeloid Maturation in DNMT3A-Mutant AML.

Holly A Gamlen, Jennifer S Romer-Seibert, Michael E Lawler

|Jan 27, 2021
Burkitt Lymphoma International Prognostic Index.

Adam J Olszewski, Lasse H Jakobsen, Graham P Collins

|Aug 01, 2020
Safety and efficacy of BAY1436032 in IDH1-mutant AML: phase I study results.

Michael Heuser, Neil Palmisiano, Ioannis Mantzaris

Pageof 1

Frequent Collaborators

1 joint publications

David F Claxton

1 joint publications

Hassan Alkhateeb

1 joint publications

Nikolai A Podoltsev

1 joint publications

Ehab L Atallah